EUVIMEDEUVIMED entdecken
Leitlinie

Simultaneous Global Drug Development and Multiregional Clinical Trials (MRCT): 5 Years After Implementation of ICH E17 Guidelines

Rominder Singh iD, William Wang, Aloka Chakravarty, Jun Wang, Yoshiaki Uyama

Therapeutic Innovation & Regulatory Science · 2024

DOI: 10.1007/s43441-024-00639-0 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Therapeutic Innovation & Regulatory Science, 2024. Verfasst von Rominder Singh und 4 weiteren Autor:innen. Beteiligte Einrichtung: Pfizer Research and Development, 10555 Science Center Dr, San Diego, CA, 92121, USA. drugdevpro@gmail.com. Hauptthemen laut MEDLINE: Drug Development. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug DevelopmentHumansClinical Trials as TopicGuidelines as TopicMulticenter Studies as TopicCOVID-19

Stichwörter der Autor:innen

Drug developmentICH E17MRCTMultiregional clinical trials

Autor:innen und Institutionen

  • Pfizer Research and Development, 10555 Science Center Dr, San Diego, CA, 92121, USA. drugdevpro@gmail.com.
  • Merck & Co., Inc, 126 East Lincoln Ave, Rahway, NJ, 07065, USA.
  • Pfizer Chief Medical Affairs Office, 66 Hudson Boulevard, New York, NY, 10001, USA.
  • Center of Drug Evaluation, National Medical Products Administration, Zone 2, No. 22 Guangde Street, Economic and Technological Development Zone, Beijing, China.
  • Regulatory Science Center, Pharmaceuticals and Medical Devices Agency, Shin‑Kasumigaseki Building, 3‑3‑2, Kasumigaseki, Chiyoda‑ku, Tokyo, 100‑0013, Japan.

ORCID-Profile: Rominder Singh

Zitieren

APA

Singh, R., Wang, W., Chakravarty, A., Wang, J., & Uyama, Y. (2024). Simultaneous Global Drug Development and Multiregional Clinical Trials (MRCT): 5 Years After Implementation of ICH E17 Guidelines. Therapeutic Innovation & Regulatory Science. https://doi.org/10.1007/s43441-024-00639-0

Vancouver

Singh R, Wang W, Chakravarty A, Wang J, Uyama Y. Simultaneous Global Drug Development and Multiregional Clinical Trials (MRCT): 5 Years After Implementation of ICH E17 Guidelines. Therapeutic Innovation & Regulatory Science. 2024. doi:10.1007/s43441-024-00639-0

BibTeX
@article{Singh2024,
  author = {Singh, Rominder and Wang, William and Chakravarty, Aloka and Wang, Jun and Uyama, Yoshiaki},
  title = {Simultaneous Global Drug Development and Multiregional Clinical Trials (MRCT): 5 Years After Implementation of ICH E17 Guidelines},
  journal = {Therapeutic Innovation & Regulatory Science},
  year = {2024},
  doi = {10.1007/s43441-024-00639-0}
}
Kostenlos starten →